Publication | Closed Access

IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy

Neuro-oncologyRadiation TherapyTemozolomide-based ChemoradiotherapyMedicinePathologyIdh1 MutationHigh-grade GliomasAnaplastic AstrocytomaCancer TreatmentRadiation OncologyOncologyGlioma